34 results on '"Grose, D."'
Search Results
2. Residence time investigation of a multiple hearth kiln using mineral tracers
3. The UK Divide: Does Having a Pembrolizumab–Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab–Chemotherapy Combination in Scotland.
4. The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Advanced Head and Neck Squamous Cell Carcinoma.
5. OC-0563: MRI based 3D reconstruction of pharyngeal cancer to aid clinical oncologists in radiotherapy treatment planning.
6. P-335 A pilot study of co-morbidity in newly diagnosed patients with lung cancer
7. P-17 Peri-operative FLOT: West of Scotland regional experience.
8. Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.
9. PO-1110 Survival outcomes in Hypopharyngeal Squamous Cell Cancers in the West of Scotland Cancer Network.
10. OC-0433 Positive predictive value of post radiotherapy FDG PET-CT is affected by treatment and HPV-status.
11. Validation of a Magnetic Resonance Imaging-based Auto-contouring Software Tool for Gross Tumour Delineation in Head and Neck Cancer Radiotherapy Planning.
12. Neoadjuvant Chemotherapy prior to Surgery in Head and Neck Cancer
13. PO-0713: Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT.
14. PD-0073: Outcomes in patients aged 70 and above treated with radical radiotherapy for head and neck cancer.
15. Combining interpolation and 3D level set method (I+3DLSM) for medical image segmentation.
16. Improving patient survival with the colorectal cancer multi-disciplinary team.
17. EP-1137 DW MRI as biomarker of response during RT for intermed/high risk SCC oropharynx: a feasibility study.
18. PO-113 DW MRI as biomarker of response during RT for intermed/high risk SCC oropharynx: a feasibility study.
19. PO-049 Management SCC unknown primary with contemporary diagnostic and radiotherapy techniques.
20. OC-023 Real life application of the PET-Neck protocol for post radiotherapy surveillance in advanced HNSCC.
21. Neoadjuvant folfirinox in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis.
22. Neoadjuvant folfirinox in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis.
23. Liver Stereotactic Ablative Radiotherapy: an Effective and Feasible Alternative to Surgery during the COVID-19 Pandemic.
24. EP-1405 Feasibility study of fiducial markers in oesophageal cancer radiotherapy.
25. EP-1136 Management SCC unknown primary with contemporary diagnostic and radiotherapy techniques.
26. PO-060 Outcomes from concomitant cetuximab with radiotherapy in HNSCC: A retrospective cohort study.
27. OC-024 12 week PET-CTs have a low PPV for nodal residual disease in HPV positive oropharygeal cancers.
28. Combining interpolation and 3D level set method (I+3DLSM) for medical image segmentation.
29. PO-129: Late xerostomia in VMAT for oropharyngeal cancer: dosimetric analysis of parotids outside the PTV.
30. EP-1096: VMAT in oropharyngeal cancer: Dosimetric analysis of parotids outside the PTV and correlation with toxicity results.
31. EP-1177 IMRT FOR HEAD & NECK CANCER-IS THERE A CORRELATION BETWEEN MEAN CONTRALATERAL PAROTID DOSE AND LATE ORAL TOXICITY?
32. PO-0720 INDUCTION TPF CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK CANCER – TOXICITY AND CLINICAL OUTCOMES
33. PD-0084 EFFECTS OF MRI SCAN POSITION ON CT IMAGE REGISTRATION AND TARGET DELINEATION FOR OROPHARYNX CANCER VMAT PATIENTS
34. INDUCTION CHEMOTHERAPY WITH TPF PRIOR TO SURGERY – A CASE SERIES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.